PetarSLenertMDPhD

PubMed

• Tongue necrosis as a manifestation of immune dysfunction: A complex case of systemic lupus erythematosus, histoplasmosis, and macrophage activation syndrome.
  Madalyn Walsh, Alick Feng, Petar Lenert, Bharat Kumar> ;Clinical Case Reports. 2023 Jul 1
• Rare Case of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Monoclonal Gammopathy of Undetermined Significance.
  Alpana Garg, Alexander A Garza, Sachin Goyal, Petar Lenert> ;The American Journal of Case Reports. 2023 Apr 26
• 3 citations
  The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythe...
  Erin Sternhagen, Brittany Bettendorf, Aleksander Lenert, Petar S Lenert> ;Journal of Inflammation Research. 2022 Jan 1
• 1 citations
  Atypical Large Vessel Vasculitis Presenting With Cholestatic Liver Abnormalities: Case-Based Review.
  Sameet Sangha, Aleksander Lenert, Salma Dawoud, Aneet Kaur, Hasan Yazan, Michael D. Voigt, Petar Lenert> ;Journal of Clinical Rheumatology. 2021 Dec 1
• A Patient With Back Pain and Morning Stiffness.
  Sameet Sangha, Petar Lenert, Bharat Kumar> ;JAMA. 2020 Sep 22
• 4 citations
  Risk of Recurrent Staphylococcus aureus Prosthetic Joint Infection in Rheumatoid Arthritis Patients-A Nationwide Cohort Study.
  Namrata Singh, Rajeshwari Nair, Michihiko Goto, Martha L. Carvour, Ryan M. Carnahan, Elizabeth H. Field, Petar Lenert, Mary Vaughan-Sarrazin, Marin L. Schweizer, Eli N...> ;Open Forum Infectious Diseases. 2019 Oct 19
• 6 citations
  Interstitial lung disease associated with anti-PM-Scl antibody: A single center experience.
  Kamonpun Ussavarungsi, Kenneth Nugent, Alicia K. Gerke, Matthew D. Krasowski, Rebecca Tuetken, Petar Lenert> ;Autoimmunity Reviews. 2019 Sep 1
• 36 citations
  Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis
  Bharat Kumar, Jennifer Strouse, Melissa L Swee, Petar Lenert, Manish Suneja> ;Seminars in Arthritis and Rheumatism. 2018 Jan 12
• 9 citations
  Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?
  Umang Swami, Petar Lenert, Muhammad Furqan, Taher Abu Hejleh, Gerald H. Clamon, Jun Zhang> ;Journal of Thoracic Oncology. 2018 Jun 1
• 2 citations
  Abnormal thymic maturation and lymphoproliferation in MRL-Faslpr/lpr mice can be partially reversed by synthetic oligonucleotides: implications for systemic lupus eryt...
  R F Ashman, N Singh, Petar Lenert> ;Lupus. 2017 Jun 1
• 24 citations
  Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date.
  Aleksander Lenert, Timothy B. Niewold, Petar Lenert> ;Drug Design, Development and Therapy. 2017 Mar 13
• 59 citations
  Joint Hypermobility Syndrome: Recognizing a Commonly Overlooked Cause of Chronic Pain
  Bharat Kumar, Petar Lenert> ;The American Journal of Medicine. 2017 Jun 1
• 24 citations
  Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice
  Aleksander Lenert, Petar Lenert> ;Clinical Rheumatology. 2017 Jan 1
• 3 citations
  Gout and African Americans: Reducing disparities.
  Bharat Kumar, Petar Lenert> ;Cleveland Clinic Journal of Medicine. 2016 Sep 1
• Hypopyon complicating the course of anterior uveitis in a patient with Behcet's syndrome.
  Namrata Singh, Petar Lenert> ;Clinical Case Reports. 2016 Aug 15
• 7 citations
  Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations
  Namrata Singh, Bharat Kumar, Vijay Aluri, Petar Lenert> ;The Journal of Allergy and Clinical Immunology. 2016 May 1
• 27 citations
  Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome
  Christie P. Thomas, Carla M. Nester, Andrew C. Phan, Manisha Sharma, Amanda L. Steele, Petar Lenert> ;Clinical Kidney Journal. 2015 Dec 1
• 32 citations
  Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
  Aleksander Lenert, Petar Lenert> ;Drug Design, Development and Therapy. 2015 Jan 7
• 31 citations
  ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review
  Petar Lenert, Michael S. Icardi, Laila Dahmoush> ;Clinical Rheumatology. 2013 Apr 21
• 15 citations
  Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.
  Damir Matesic, Aleksander Lenert, Petar Lenert> ;Current Allergy and Asthma Reports. 2012 Feb 1
• 15 citations
  B cells do not take up bacterial DNA: an essential role for antigen in exposure of DNA to toll-like receptor-9
  Tara L. Roberts, Marian L. Turner, Jasmyn A. Dunn, Petar Lenert, Ian L. Ross, Matthew J. Sweet, Katryn J. Stacey> ;Immunology and Cell Biology. 2011 May 1
• 6 citations
  Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9
  Robert F. Ashman, J. Adam Goeken, Petar Lenert> ;International Immunopharmacology. 2011 Aug 1
• 29 citations
  Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding.
  Robert F. Ashman, J. Adam Goeken, Eicke Latz, Petar Lenert> ;International Immunology. 2011 Mar 1
• 6 citations
  Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
  T. Layer, A. Steele, J. A. Goeken, S. Fleenor, Petar Lenert> ;Clinical and Experimental Immunology. 2011 Jan 14
• 19 citations
  FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses.
  Ana M. Avalos, Melissa B. Uccellini, Petar Lenert, Gregory A. Viglianti, Ann Marshak-Rothstein> ;European Journal of Immunology. 2010 Oct 1
• Join now to see all

Lectures

• Hydralazine-Associated Vasculitis: Overlapping Features of Drug-Induced Lupus and Vasculitis 
  UI Carver College of Medicine, Coralville, Iowa - 6/1/2012